A study presented today at the Canadian Cardiovascular Congress has identified the genetic mutations that account for a significant proportion of cases of familial dilated cardiomyopathy (DCM), a disease affecting thousands of Canadians.
A lifestyle program focused on high-intensity interval training combined with nutritional counselling on the Mediterranean diet have shown dramatic results for improving the heart health of people with abdominal obesity, finds a study released at the Canadian Cardiovascular Congress.
A study conducted by the team of Dr. Jean-Claude Tardif, Director of the Research Centre at the Montreal Heart Institute (MHI), has led to the discovery of a new approach to treat aortic valve stenosis through the administration of a compound that prevents valve deterioration and can even reverse the progression of the disease.
A study from the Montreal Heart Institute (MHI) that was published in the Journal of the American College of Cardiology confirms that high-intensity endurance exercise practised over the long-term can be harmful to the heart for certain athletes, making them more at risk of suffering from atrial fibrillation (AF).
Dr. Stanley Nattel, a clinical cardiologist and Director of the Electrophysiology Research Axis at the Research Centre of the Montreal Heart Institute (MHI), has received the prestigious 2013 Founders Lectureship Award from the Heart Rhythm Society. Every year in May, this professional association honours a scientist who has made a unique and significant contribution in the field of cardiac pacing and electrophysiology.
It’s on Saturday that the Journal of the American Heart Association published the conclusive results from a study directed by Dr. Éric Thorin of the Montreal Heart Institute (MHI), which suggests for the first time that a blood protein contributes to the early development of atherosclerosis.
Dr. Denis Roy, Executive Director of the Montreal Heart Institute (MHI), along with Dr. Jean-Claude Tardif, Director of the MHI Research Centre, are pleased to announce the appointment of Mr. Denis Bilodeau to the position of Director, Strategy and Innovation of the MHI Research Centre, as of April 15, 2013.
The Research Centre of the Montreal Heart Institute (MHI) achieved incredible results in the prestigious 2012 Genomics and Personalized Health national competition funded by Genome Canada and the CIHR. Dr. Jean-Claude Tardif and Dr. John D. Rioux from the MHI each received $10 million for research into personalized medicine.
A single dose of an investigational anti-inflammatory drug called inclacumab considerably reduces damage to heart muscle during angioplasty (the opening of a blocked artery), according to a recent international clinical trial spearheaded by Dr. Jean-Claude Tardif, Director of the Research Centre at the Montreal Heart Institute, affiliated to the University of Montreal.
The Montreal Heart Institute (MHI) has become the first hospital in North America where patients can benefit from a GPS system that lets cardiologists accurately navigate the heart during procedures to treat cardiac rhythm disorders. Developed by St. Jude Medical, MediGuide Technology considerably reduces radiation exposure by producing a full three-dimensional (3D) image of the heart from pre-recorded X-rays.
